Monday, May 29, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from UCB Pharma
Steering Committee Chair
Professor
Health Science Faculty
University of Copenhagen
Copenhagen, Denmark
Chairman
Department of Dermatology
Zealand University Hospital
Roskilde, Denmark
Steering Committee Member
Associate Professor and Vice Chair for Education
Department of Dermatology
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
Steering Committee Member
Associate Professor of Dermatology
Department of Dermatology
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Steering Committee Member
Director
Departments of Dermatology, Venereology, Allergology and Immunology
Dessau Medical Center
Professor of Dermatology and Venereology
Brandenburg Medical School Theodor Fontane
Dessau, Germany
Steering Committee Member
Associate Professor
Department of Dermatology
Nordland Hospital Trust
Bodø, Norway
Institute of Clinical Medicine
University of Tromsø
Tromsø, Norway
Steering Committee Member
Senior Staff Dermatologist
Department of Dermatology
Henry Ford Hospital
Detroit, Michigan, United States
Steering Committee Chair
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie; Chemocentryx; Coloplast; Incyte; Inflarx; Kymera; Leo Pharma; Novartis; UCB; Union Therapeutics; Wella
Received grants for clinical research from: AbbVie; AstraZeneca; CSL; Inflarx; Janssen-Cilag; Leo Pharma; Novartis; Regeneron; Sanofi
Owns stock, stock options, or bonds from: Through pensionfunds and Bavarian Nordic
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie; Bayer; ChemoCentryx; Incyte; Janssen; Novartis; UCB
Served as a speaker or a member of a speakers bureau for: AbbVie
Received grants for clinical research from: Incyte
Other: receive royalties from or am a patent beneficiary of: HiSQOL measure
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbvie; InflaRx; Novartis; UCB
Served as a speaker or a member of a speakers bureau for: Abbvie; Novartis
Received grants for clinical research from: Abbvie; Chemocentryx; Incyte; InflaRx; Novartis; UCB
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AccureAcne; Bayer Healthcare; GlaxoSmithKline/Stiefel; Incyte; Inflarx; L´OREAL; PPM; Regeneron; UCB
Received grants for clinical research from: AbbVie; Amgen; Incyte; Inflarx; Novartis; PPM; Relaxera; UCB
Other: Scientific lectures for AbbVie; Amgen
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbvie; UCB
Served as a speaker or a member of a speakers bureau for: Abbvie
Other: I participate as national coordinator and primary investigator in phase 2 trial sponsored from Boehringer Ingelheim for the treatment of hidradenitis suppurativa. I do not receive any compensation regarding this and budget and funds are going to hospital budget
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie; Boehringer Ingelheim; Clarify Medical; HS Foundation; Incyte; Jansen; Pfizer; UCB
Received grants for clinical research from: Bayer; Chemocentyx; Incyte; Lenicura; Pfizer Inc.
